| Metric | შპს Linema Pharm | შპს ნ-ფარმა | შპს ფარმაჰაბი |
|---|---|---|---|
| Growth | |||
| Revenue | ₾3.6m₾3.9m | ₾2.8m₾1.2m | ₾5.5m₾2.1m |
| Revenue growth | -8.7% | 143.7% | 158.9% |
| Profitability | |||
| EBITDA | ₾1.5m₾1.6m | ₾703k₾309k | ₾1.0m₾698k |
| EBITDA margin | 41.4%40.5% | 24.7%26.4% | 18.8%33.0% |
| Net profit | ₾1.3m₾1.5m | ₾686k₾308k | |
| ₾1.1m₾698k |
| Net margin | 36.5%38.9% | 24.1%26.3% | 19.8%33.0% |
| Balance sheet | |||
| Total assets | ₾6.8m₾6.3m | ₾2.1m₾1.5m | ₾2.1m₾1.5m |
| Total equity | ₾6.3m₾5.6m | ₾1.8m₾1.2m | ₾1.8m₾698k |
| ROE | 20.7%27.1% | 38.7%26.6% | 60.8%100.0% |